如何管理数据库检测到的大量交互?关于数据库检测药物相互作用风险管理的焦点小组会议研究。

IF 1.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Dénes Kleiner, Faraz Haghverdi, Orsolya Szépe, István László Horváth, Szilvia Sebők, Dezső Csupor, András Horváth, Artúr György Balogh, Katalin Monostory, László Kóbori, Máté Balázs, Magdolna Dank, Csaba Mihály Móczár, Ádám Becze, András Süle, Romána Zelkó
{"title":"如何管理数据库检测到的大量交互?关于数据库检测药物相互作用风险管理的焦点小组会议研究。","authors":"Dénes Kleiner, Faraz Haghverdi, Orsolya Szépe, István László Horváth, Szilvia Sebők, Dezső Csupor, András Horváth, Artúr György Balogh, Katalin Monostory, László Kóbori, Máté Balázs, Magdolna Dank, Csaba Mihály Móczár, Ádám Becze, András Süle, Romána Zelkó","doi":"10.1136/ejhpharm-2025-004478","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Database-assisted screening may help detect the risks of drug interactions, but less than 10% of flagged interactions have clinical manifestations, potentially leading to alert fatigue among healthcare providers. To address this issue, this study aimed to develop a concise framework to support the management of database-indicated interaction risks.</p><p><strong>Methods: </strong>A grounded theory approach was used to design, evaluate and develop the framework. Participants included healthcare professionals and laypersons with experience using narrow therapeutic index medications, as well as individuals recommended by them. Two focus group discussions were conducted (N<sub>1</sub>=6 and N<sub>2</sub>=5), each lasting approximately 2 hours and following the same agenda. In one case, a follow-up one-on-one interview was held because the participant indicated further insights at the end of the session.</p><p><strong>Results: </strong>Participants identified key decision-making questions for the framework, including the evidence base for interacting drugs, severity and documentation level of the interaction, availability of safer alternatives, and the presence of confounding factors. The framework was considered useful and, following refinement, potentially suitable for clinical implementation. A key insight was that integration into healthcare curricula is essential for achieving long-term impact. Overall, the proposed tool may assist in managing interaction risks in diverse clinical scenarios and reduce alert fatigue among healthcare professionals.</p><p><strong>Conclusion: </strong>Although further clinical validation is needed, the framework provides a foundation for improving the management of database-detected drug interactions.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"How to manage the overwhelming amount of database-detected interactions? A focus group meeting study on the management of database-detected risks of drug interactions.\",\"authors\":\"Dénes Kleiner, Faraz Haghverdi, Orsolya Szépe, István László Horváth, Szilvia Sebők, Dezső Csupor, András Horváth, Artúr György Balogh, Katalin Monostory, László Kóbori, Máté Balázs, Magdolna Dank, Csaba Mihály Móczár, Ádám Becze, András Süle, Romána Zelkó\",\"doi\":\"10.1136/ejhpharm-2025-004478\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Database-assisted screening may help detect the risks of drug interactions, but less than 10% of flagged interactions have clinical manifestations, potentially leading to alert fatigue among healthcare providers. To address this issue, this study aimed to develop a concise framework to support the management of database-indicated interaction risks.</p><p><strong>Methods: </strong>A grounded theory approach was used to design, evaluate and develop the framework. Participants included healthcare professionals and laypersons with experience using narrow therapeutic index medications, as well as individuals recommended by them. Two focus group discussions were conducted (N<sub>1</sub>=6 and N<sub>2</sub>=5), each lasting approximately 2 hours and following the same agenda. In one case, a follow-up one-on-one interview was held because the participant indicated further insights at the end of the session.</p><p><strong>Results: </strong>Participants identified key decision-making questions for the framework, including the evidence base for interacting drugs, severity and documentation level of the interaction, availability of safer alternatives, and the presence of confounding factors. The framework was considered useful and, following refinement, potentially suitable for clinical implementation. A key insight was that integration into healthcare curricula is essential for achieving long-term impact. Overall, the proposed tool may assist in managing interaction risks in diverse clinical scenarios and reduce alert fatigue among healthcare professionals.</p><p><strong>Conclusion: </strong>Although further clinical validation is needed, the framework provides a foundation for improving the management of database-detected drug interactions.</p>\",\"PeriodicalId\":12050,\"journal\":{\"name\":\"European journal of hospital pharmacy : science and practice\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2025-07-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European journal of hospital pharmacy : science and practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1136/ejhpharm-2025-004478\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of hospital pharmacy : science and practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/ejhpharm-2025-004478","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

目的:数据库辅助筛选可能有助于发现药物相互作用的风险,但不到10%的标记相互作用有临床表现,可能导致医疗保健提供者警惕疲劳。为了解决这个问题,本研究旨在开发一个简洁的框架来支持数据库指示的交互风险管理。方法:采用扎根理论的方法来设计、评估和开发该框架。参与者包括医疗保健专业人员和具有使用窄治疗指数药物的经验的外行人,以及他们推荐的个人。进行了两次焦点小组讨论(N1=6和N2=5),每次持续约2小时,并遵循相同的议程。在一个案例中,由于参与者在会议结束时提出了进一步的见解,因此进行了后续的一对一访谈。结果:参与者确定了框架的关键决策问题,包括相互作用药物的证据基础、相互作用的严重程度和文件水平、更安全替代品的可用性以及混杂因素的存在。该框架被认为是有用的,并且经过改进,可能适合临床实施。一个关键的见解是,将其纳入保健课程对于实现长期影响至关重要。总的来说,建议的工具可以帮助管理不同临床场景中的交互风险,并减少医疗保健专业人员的警惕疲劳。结论:虽然需要进一步的临床验证,但该框架为改善数据库检测药物相互作用的管理提供了基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
How to manage the overwhelming amount of database-detected interactions? A focus group meeting study on the management of database-detected risks of drug interactions.

Objectives: Database-assisted screening may help detect the risks of drug interactions, but less than 10% of flagged interactions have clinical manifestations, potentially leading to alert fatigue among healthcare providers. To address this issue, this study aimed to develop a concise framework to support the management of database-indicated interaction risks.

Methods: A grounded theory approach was used to design, evaluate and develop the framework. Participants included healthcare professionals and laypersons with experience using narrow therapeutic index medications, as well as individuals recommended by them. Two focus group discussions were conducted (N1=6 and N2=5), each lasting approximately 2 hours and following the same agenda. In one case, a follow-up one-on-one interview was held because the participant indicated further insights at the end of the session.

Results: Participants identified key decision-making questions for the framework, including the evidence base for interacting drugs, severity and documentation level of the interaction, availability of safer alternatives, and the presence of confounding factors. The framework was considered useful and, following refinement, potentially suitable for clinical implementation. A key insight was that integration into healthcare curricula is essential for achieving long-term impact. Overall, the proposed tool may assist in managing interaction risks in diverse clinical scenarios and reduce alert fatigue among healthcare professionals.

Conclusion: Although further clinical validation is needed, the framework provides a foundation for improving the management of database-detected drug interactions.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.40
自引率
5.90%
发文量
104
审稿时长
6-12 weeks
期刊介绍: European Journal of Hospital Pharmacy (EJHP) offers a high quality, peer-reviewed platform for the publication of practical and innovative research which aims to strengthen the profile and professional status of hospital pharmacists. EJHP is committed to being the leading journal on all aspects of hospital pharmacy, thereby advancing the science, practice and profession of hospital pharmacy. The journal aims to become a major source for education and inspiration to improve practice and the standard of patient care in hospitals and related institutions worldwide. EJHP is the only official journal of the European Association of Hospital Pharmacists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信